Author

Manuela Lombardi

Unknown affiliation - Cited by 2,062 - medicine

Biography

Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most successful modern pathogens. The same organism that lives as a commensal and is transmitted in both health-care and community settings is also a leading cause of bacteraemia, endocarditis, skin and soft tissue infections, bone and joint infections and hospital-acquired infections. 
Title
Cited by
Year
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research
NA Turner, BK Sharma-Kuinkel, SA Maskarinec, EM Eichenberger, ...Nature Reviews Microbiology 17 (4), 203-218, 2019201
1069
2019
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study
S Aliberti, LF Reyes, P Faverio, G Sotgiu, S Dore, AH Rodriguez, NJ Soni, ...The Lancet Infectious diseases 16 (12), 1364-1376, 2016201
122
2016
High-dose daptomycin therapy for left-sided infective endocarditis: a prospective study from the international collaboration on endocarditis
M Carugati, AS Bayer, JM Miró, LP Park, AC Guimarães, A Skoutelis, ...Antimicrobial agents and chemotherapy 57 (12), 6213-6222, 2013201
115
2013
Prevalence and etiology of community-acquired pneumonia in immunocompromised patients
MF Di Pasquale, G Sotgiu, A Gramegna, D Radovanovic, S Terraneo, ...Clinical Infectious Diseases 68 (9), 1482-1493, 2019201
111
2019
Effect of algorithm-based therapy vs usual care on clinical success and serious adverse events in patients with staphylococcal bacteremia: a randomized clinical trial
TL Holland, I Raad, HW Boucher, DJ Anderson, SE Cosgrove, PS Aycock, ...Jama 320 (12), 1249-12, 2018201
58
2018
Systemic lupus erythematosus and HIV infection: a whimsical relationship. Reports of two cases and review of the literature
M Carugati, M Franzetti, A Torre, R Giorgi, A Genderini, ...Clinical rheumatology 32, 1399-1405, 201356201
56
2013
Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report
M Franzetti, U Pozzetti, M Carugati, A Pandolfo, C Molteni, P Faccioli, ...International Journal of Infectious Diseases 97, 215-218, 2020202
56
2020
De-escalation therapy among bacteraemic patients with community-acquired pneumonia
M Carugati, F Franzetti, T Wiemken, R Kelly, P Peyrani, F Blasi, J Ramirez, ...Clinical Microbiology and Infection 21 (10), 936. e11-936. e18, 2015201
47
2015
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia
S Aliberti, GS Cook, BL Babu, LF Reyes, AH Rodriguez, F Sanz, NJ Soni, ...Journal of Infection 79 (4), 300-311, 2019201
42
2019
Incidence of human brucellosis in the Kilimanjaro Region of Tanzania in the periods 2007–2008 and 2012–2014
M Carugati, HM Biggs, MJ Maze, RA Stoddard, S Cash-Goldwasser, ...Transactions of The Royal Society of Tropical Medicine and Hygiene 112 (3 …, 2018201
34
2018
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study
M Carugati, S Aliberti, LF Reyes, RF Sadud, M Irfan, C Prat, NJ Soni, ...ERJ open research 4 (4), 2018201
32
2018
An international perspective on hospitalized patients with viral community-acquired pneumonia
D Radovanovic, G Sotgiu, M Jankovic, PA Mahesh, PJ Marcos, MI Abdalla, ...European journal of internal medicine 60, 54-70, 2019201
32
2019
Exogenous reinfection of tuberculosis in a low-burden area
C Schiroli, M Carugati, F Zanini, A Bandera, S Di Nardo Stuppino, ...Infection 43, 647-653, 2015201
30
2015
Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point …
M Carugati, S Aliberti, G Sotgiu, F Blasi, A Gori, R Menendez, M Encheva, ...European Journal of Clinical Microbiology & Infectious Diseases 39, 1513-1525, 2020202
27
2020
How to choose the duration of antibiotic therapy in patients with pneumonia
BF Aliberti S, Giuliani F, Bonaiti G, Faverio P, Carugati M, Spoletini G ...Curr Opin Infect Dis 28, 177-184, 2015201
23
2015
International Collaboration on Endocarditis. High-dose daptomycin therapy for left-sided infective endocarditis: a prospective study from the International Collaboration on …
M Carugati, AS Bayer, JM Miró, LP Park, AC Guimarães, A Skoutelis, ...Antimicrob Agents Chemother 57 (12), 6213-22, 131
20
2013
Management of acute respiratory failure due to community-acquired pneumonia: a systematic review
NM Vanoni, M Carugati, N Borsa, G Sotgiu, L Saderi, A Gori, M Mantero, ...Medical Sciences 7 (1), 10, 191
20
2019
Aspiration risk factors, microbiology, and empiric antibiotics for patients hospitalized with community-acquired pneumonia
J Marin-Corral, S Pascual-Guardia, F Amati, S Aliberti, JR Masclans, ...Chest 159 (1), 58-72, 2021202
19
2021
Individualizing duration of antibiotic therapy in community-acquired pneumonia
S Aliberti, J Ramirez, F Giuliani, T Wiemken, G Sotgiu, S Tedeschi, ...Pulmonary Pharmacology & Therapeutics 45, 1-201, 2017201
19
2017
Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with …
JM Pericàs, JA Messina, C Garcia-de-la-Mària, L Park, ...Clinical Microbiology and Infection 23 (8), 544-549, 202
17
2017

Referred From: https://scholar.google.com/citations?user=HYBhBbUAAAAJ&hl=en

Cited by
Citations 2062
h-index 19
i10-index 25
Recommended Journals
Open Access Journals